% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • mr_ssssamsa mr_ssssamsa Sep 2, 2012 11:30 PM Flag

    Medivation drug approved

    Approval was expected but it came 3 months ahead of the PDUFA date.

    Given the apparent synergies, at least preclinically, with 0GX-011 for which OGXI presented evidence at ASCO 2011, it's conceivable that Teva would now fund a combination trial. I think it's more likely that they'll wait until MDVN shows efficacy in the larger pre-chemo setting. By then they may have results from SYNERGY, and that will probably be the main factor determining whether they want to initiate additional new trials of 011.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.3705+0.1145(+30.90%)Oct 25 4:00 PMEDT